These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27913089)

  • 1. A combined one-stage surgical approach of orbital tumor debulking, lid reconstruction, and ptosis repair in children with orbitotemporal neurofibromatosis.
    Keren S; Dotan G; Ben-Cnaan R; Leibovitch L; Leibovitch I
    J Plast Reconstr Aesthet Surg; 2017 Mar; 70(3):336-340. PubMed ID: 27913089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical features and surgical management of orbitotemporal neurofibromatosis].
    Cui Y; Li Y; Hou ZJ; Ding JW; Li DM
    Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):828-833. PubMed ID: 31715679
    [No Abstract]   [Full Text] [Related]  

  • 3. Orbitotemporal neurofibromatosis. Clinical features and surgical management.
    Lee V; Ragge NK; Collin JR
    Ophthalmology; 2004 Feb; 111(2):382-8. PubMed ID: 15019395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas.
    Avery RA; Dombi E; Hutcheson KA; Acosta MT; Baldwin AM; Madigan WP; Gillespie A; Fitzgibbon EJ; Packer RJ; Widemann BC
    Am J Ophthalmol; 2013 Jun; 155(6):1089-1094.e1. PubMed ID: 23453281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Removal and plastic reconstructive surgery of orbital neurofibroma].
    Fan XQ; Lin M; Li J; Zhou HF; Fu Y
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3264-7. PubMed ID: 18396621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blepharoplasty techniques in the management of orbito-temporal neurofibromatosis.
    Li J; Lin M; Shao C; Ge S; Fan X
    J Plast Reconstr Aesthet Surg; 2014 Nov; 67(11):1496-501. PubMed ID: 25128221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of facial disfigurement in orbitotemporal neurofibromatosis.
    Coban-Karatas M; Altan-Yaycioglu R; Bal N; Akova YA
    Ophthalmic Plast Reconstr Surg; 2010; 26(2):124-6. PubMed ID: 20305516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodelling the upper eyelid in the management of orbitopalpebral neurofibromatosis.
    Marchac D; Britto JA
    Br J Plast Surg; 2005 Oct; 58(7):944-56. PubMed ID: 16043142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical correction in orbitotemporal neurofibromatosis with dystopia.
    Choi MSS; Choi SH; Lee JH
    BMC Ophthalmol; 2016 Jan; 16():4. PubMed ID: 26744073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, radiological features and surgical strategies for 23 NF1 patients with intraorbital meningoencephalocele.
    Niu J; Wang J; Wang D; He X; Li Z; Li X; Su F; Jia W
    Neurol Sci; 2019 Jun; 40(6):1217-1225. PubMed ID: 30868483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical care burden in orbito-temporal neurofibromatosis: Multiple procedures and surgical care duration analysis in 47 consecutive adult patients.
    Pessis R; Lantieri L; Britto JA; Leguerinel C; Wolkenstein P; Hivelin M
    J Craniomaxillofac Surg; 2015 Oct; 43(8):1684-93. PubMed ID: 26210305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome.
    Chaudhry IA; Morales J; Shamsi FA; Al-Rashed W; Elzaridi E; Arat YO; Jacquemin C; Oystreck DT; Bosley TM
    Eye (Lond); 2012 Apr; 26(4):583-92. PubMed ID: 22193879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orbitotemporal neurofibromatosis: classification and treatment.
    Erb MH; Uzcategui N; See RF; Burnstine MA
    Orbit; 2007 Dec; 26(4):223-8. PubMed ID: 18097958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical management of type II orbital neurofibromatosis].
    Lin M; Li J; Zhou HF; Fu Y; Fan XQ
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2008 Sep; 24(5):347-9. PubMed ID: 19119632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: "management of facial disfigurement in orbitotemporal neurofibromatosis".
    Tawfik HA; Shafik A
    Ophthalmic Plast Reconstr Surg; 2011; 27(3):226; author reply 226. PubMed ID: 21088630
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of orbital plain radiographs for orbital deformities in neurofibromatosis type 1 patients, with special reference to alterations of the orbital rim as indicators of adjacent plexiform neurofibroma.
    Friedrich RE; Rother J; Christ G; Lehmann M; Eulenburg CG; Giese M; Scheuer HA
    Anticancer Res; 2013 Mar; 33(3):1081-90. PubMed ID: 23482785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term visual outcomes in patients with orbitotemporal neurofibromatosis.
    Greenwell TH; Anderson PJ; Madge SK; Selva D; David DJ
    Clin Exp Ophthalmol; 2014 Apr; 42(3):266-70. PubMed ID: 23926960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of an expansile orbital mass: Plexiform neurofibroma decompression by orbitozygomatic approach.
    Kovatch KJ; Purkey MT; Martinez-Lage M; Gausas RE; Loevner LA; Grady MS; O'Malley BW; Rassekh CH
    Laryngoscope; 2015 Nov; 125(11):2457-60. PubMed ID: 25960281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for simultaneous double eyelid blepharoplasty in Asian patients with congenital blepharoptosis.
    Park DH; Kim CW; Shim JS
    Aesthetic Plast Surg; 2008 Jan; 32(1):66-71. PubMed ID: 17955284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated With Surgical Outcomes in Congenital Ptosis: A 10-Year Study of 319 Cases.
    Ho YF; Wu SY; Tsai YJ
    Am J Ophthalmol; 2017 Mar; 175():173-182. PubMed ID: 28040525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.